Insider · CIK 0001456849
Kapil Dhingra
director
Files at BDTX (Black Diamond Therapeutics, Inc.), REPL (Replimune Group, Inc.), LVTX (LAVA Therapeutics NV), CRGX (CARGO Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | CRGX CARGO Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Aug 19, 2025 |
| Jun 18, 2025 | CRGX CARGO Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 20, 2025 |
| Jun 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,550 | $0.00 | $0 | 30,550 | Jun 12, 2025 |
| Apr 1, 2025 | REPL Replimune Group, Inc. | AGrant or award Stock Option (right to buy)derivative | +32,000 | $0.00 | $0 | 32,000 | Apr 3, 2025 |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | AGrant or award Common Shares (Right to Buy)derivative | +33,390 | $0.00 | $0 | 33,390 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.